Covered recipient · General Payments record
MEREDITH L FOX
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2024
$1,417.10
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.11 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $70.79 | 4 |
| Abbott Laboratories | $37.81 | 2 |
| Novo Nordisk AS | $31.82 | 2 |
| Acerta Pharma LLC | $30.71 | 2 |
| Lilly USA, LLC | $29.21 | 2 |
| ITI, Inc. | $20.36 | 1 |
| DEXCOM, INC. | $19.01 | 1 |
| ABBVIE INC. | $17.43 | 1 |
| Astellas Pharma US Inc | $16.56 | 1 |
| Axsome Therapeutics, Inc. | $15.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.60 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125224816 | CMS |
| Abbott Laboratories | $17.21 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125224820 | CMS |
| ABBVIE INC. | $17.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107124828 | CMS |
| Astellas Pharma US Inc | $16.56 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139490112 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.61 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105538733 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.10 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104211191 | CMS |
| Axsome Therapeutics, Inc. | $15.41 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148393169 | CMS |
| Dexcom, Inc. | $19.01 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153379161 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.36 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143452088 | CMS |
| Lilly USA, LLC | $14.16 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135746184 | CMS |
| Lilly USA, LLC | $15.05 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135844943 | CMS |
| Novo Nordisk Inc | $14.25 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100384097 | CMS |
| Novo Nordisk Inc | $17.57 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100481859 | CMS |
| PFIZER INC. | $27.90 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131178769 | CMS |
| PFIZER INC. | $14.05 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131044458 | CMS |
| PFIZER INC. | $13.74 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132028325 | CMS |
| PFIZER INC. | $15.10 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130879686 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.